Nuvo Pharmaceuticals Inc NRIFF

RE: Bloomberg

[alpi1441]

Was this paragraph in the original story as it now shows as (update1). "Nuvo seeks to have Pennsaid approved for use by patients with osteoarthritis, which destroys the cartilage that cushions the joints between the bones and is the most common form of arthritis. Studies showed the medicine doesn't carry the same increased risk of heart attacks and stroke as the other drugs in that category, called non-steroidal anti-inflammatory drugs, the company said."